ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2802

Comparison of the Clinical, Serological, and Prognostic Differences Among Juvenile-, Adult-, and Late-Onset Lupus Nephritis in Korean Patients: A Case-Control Study

Jeong-Won Lee1, Ji-Hyoun Kang2, Dong-Jin Park2, Yi-Rang Yim1, Ji-Eun Kim1, Kyung-Eun Lee2, Lihui Wen1, Tae-Jong Kim3, Yong-Wook Park2 and Shin-Seok Lee3, 1Chonnam National University Medical School and Hospital, Gwangju, South Korea, 2Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, 3Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, The Republic of

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Lupus

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster III: Biomarkers and Nephritis

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  SLE patients present with different clinical and serological manifestations according to the age at disease onset. However, it is not known whether there is an association between disease onset age and the clinical presentation of lupus nephritis (LN). Therefore, we investigated whether LN patients could be distinguished based on the time of disease onset and, if so, whether the groups differed in their clinical, laboratory features and long-term prognosis in ethnically homogeneous Korean patients.

Methods:  We enrolled 117 SLE patients with available clinical data at the time of renal biopsy for LN from the lupus cohort at Chonnam National University Hospital. We divided the LN patients according to the age at LN diagnosis into three groups [juvenile-onset LN (JLN), diagnosed at ≤ 18 years; adult-onset LN (ALN), diagnosed at 18–50 years; and late-onset LN (LLN), diagnosed at >50 years] and compared the baseline demographic, clinical, histological, and relevant laboratory findings. We also compared the treatment and long-term prognosis of LN according to those three groups.

Results:  Of the 114 LN patients, 20 (17.5%), 84 (71.8%), and 13 (11.1%) had JLN, ALN, and LLN, respectively. LLN patients were less educated than ALN and JLN patients (p < 0.001). Hypertension and diabetes mellitus at the onset of LN were more common in LLN patients than ALN or JLN patients (p < 0.001 and p = 0.037, respectively). Regarding the laboratory findings, LLN patients had a higher white blood cell count and lower eGFR than ALN or JLN patients (p < 0.011 and 0.002, respectively). Histologically, LLN patients had more chronicity indices and a higher chronic score (p = 0.006, p = 0.019, p < 0.001 and p < 0.001, respectively). Anti-Ro antibodies were found more frequently in ALN patients and less frequently in JLN patients (p = 0.024) and lower complement levels were more common in JLN patients and less common in LLN patients (p < 0.011 and 0.002, respectively). During a mean follow-up of 76.5 months, the development of chronic kidney disease and death from any cause were higher in LLN patients than in JLN and ALN patients (p = 0.028 and p = 0.038, respectively).

Conclusion:  LN patients present with different clinical and serological manifestations according to age at disease onset. Interestingly, LLN patients had more chronicity at the time of renal biopsy, and more deterioration of kidney function and death on long-term follow-up, than JLN and ALN patients. Therefore, LLN patients should be monitored and managed carefully to avoid poor outcomes.


Disclosure: J. W. Lee, None; J. H. Kang, None; D. J. Park, None; Y. R. Yim, None; J. E. Kim, None; K. E. Lee, None; L. Wen, None; T. J. Kim, None; Y. W. Park, None; S. S. Lee, None.

To cite this abstract in AMA style:

Lee JW, Kang JH, Park DJ, Yim YR, Kim JE, Lee KE, Wen L, Kim TJ, Park YW, Lee SS. Comparison of the Clinical, Serological, and Prognostic Differences Among Juvenile-, Adult-, and Late-Onset Lupus Nephritis in Korean Patients: A Case-Control Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/comparison-of-the-clinical-serological-and-prognostic-differences-among-juvenile-adult-and-late-onset-lupus-nephritis-in-korean-patients-a-case-control-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-the-clinical-serological-and-prognostic-differences-among-juvenile-adult-and-late-onset-lupus-nephritis-in-korean-patients-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology